Speaker Profile
President, Integrated DNA Tech
Biography
Ajay has spent over 20 years in the healthcare space spanning Life Sciences, Diagnostics and Medical Devices, and has been with Danaher since January 2025. Ajay joined IDT as President from Siemens Healthineers, where he was the President of the global Ultrasound business covering both diagnostic and interventional businesses.Prior to Siemens Healthineers, Ajay served in leadership positions at KKR, McKinsey, Federal-Mogul and Infosys Technologies. At KKR, Ajay led the portfolio operations group for the Healthcare sector covering over $40B of investments across multiple sectors. Ajay specifically led transformations at Panasonic Healthcare eventually leading to a successful IPO as well as transformations at AmSurg a large ASC network in the US. At McKinsey, as Partner, Ajay led the global medical products operations group covering devices, life sciences tools, diagnostics and pharma sectors serving clients globally in strategy, commercial, product development, manufacturing and supply chain functions. At Federal-Mogul, Ajay led plant operations and supply chain management for the sealing systems and Aftermarket businesses respectively.Ajay has an MBA from University of Michigan, Ann Arbor and a bachelors degree in Electronics and Communication Engineering from University of Mysore, India.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Victor Velculescu, Johns Hopkins University
PMWC Award Ceremony
• Klaus Pantel, University Medical Center Hamburg-Eppendorf / ELBS
• Daniel De Carvalho, University of Toronto
Keynote: Early Detection of Cancer by Multimodal Liquid Biopsy Analysis
• Klaus Pantel, UKE / ELBS
From Mutation to Methylation: The Next Wave of Liquid Biopsy Biomarkers
• Chair: Victor Velculescu, Johns Hopkins University
• Daniel De Carvalho, University of Toronto
• Manel Esteller, Sant Pau Research Institute
• Gordon Sanghera, Oxford Nanopore Technologies
Advancing Minimal Residual Disease Detection Through cfDNA & cfRNA Profiling
• Chair: Luis Diaz, Memorial Sloan Kettering Cancer Center
• Anne-Renee Hartman, Adela
• Klaus Pantel, UKE / ELBS
AI-Informed Biomarker Trials: Turning Early Signals into Actionable Designs
• Chair: Manish Kohli, University of Utah
• Luis Diaz, MSKCC
• Eric Klein, GRAIL
• Peter Bach, DELFI Diagnostics
• Samuel Levy, ClearNote Health
Role of AI in Liquid Biopsies & Cancer Detection
• Chair: Amoolya Singh, DELFI Diagnostics
• Matthew Baker, Dxcover
• Pankaj Vats, NVIDIA
Fragmentomics for Early Detection
• Varsha Rao, Claret Bioscience
Integrating Genetic Risk with Early Detection
• Giordano Botta, Allelica
Metagenomic Diagnostics & Global Pathogen Surveillance
• Charles Chiu, UCSF
AI-Driven Host–Pathogen Signatures from Plasma cfDNA
• Sivan Bercovici, Karius
Ultra-Sensitive Multimodal Liquid Biopsy for Early Cancer Detection
• Atul Sharan, CellMax Life
AI-Enhanced Proteomic Signatures for Early Cancer Detection
• Diana Abdueva, Aqtual
